Riedel and Van Tine Spotlight Sarcoma Advances and Preview Ongoing Studies

Season 5, Episode 3,   Apr 29, 2021, 08:08 PM

In our exclusive interview, Riedel and Van Tine discussed the multidisciplinary management of patients with sarcoma, the clinical impact of the FDA approval of ripretinib in the gastrointestinal stromal tumor paradigm, and other exciting advances in sarcoma.